Clinical Trial Update: Beta-Adrenergic Modulation of Drug Cue Reactivity [Phase 4]

View source ↗

Summary

This clinical trial update notes a Phase 4 study from the University of Oklahoma examining beta-adrenergic modulation of drug cue reactivity in individuals with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cigarette Smoking
• Nicotine Dependence
• Tobacco Use Disorder

Snippet

Sponsor: University of Oklahoma | Conditions: Tobacco Use Disorder, Nicotine Dependence | Phase 4 | Status: RECRUITING